Diabetes

Educational resources

Screen Shot 2019-10-22 at 11.25.04

Real-world evidence in the management of type 2 diabetes: switching from other DPP‑4 inhibitors to alogliptin (Vipidia®)

2020-02-17T09:20:00+00:00Commissioned by Takeda UK Ltd

This promotional educational webinar has been organised and funded by Takeda UK Ltd. See bottom of page for full disclaimer.

Doctor talking to patient in office_AS

Guideline for the managed introduction of biosimilar basal insulin

2019-10-09T15:02:00+01:00By Working party—Down Beba Brown Diggle Goel Milne

This guideline was developed by a multidisciplinary expert panel: Down S et al with the support of a grant from Mylan.

Doctors-with-ipad-and-device

Pancreatic exocrine insufficiency guideline

2018-05-14T08:00:00+01:00By Development group: Hambling Cummings Merriman & Widdowson

This management algorithm was developed by a multidisciplinary expert panel: Hambling C et al with the support of a grant from Mylan Ltd.